# Terbutaline Sulfate

NDC: 0404-9962
Generic name: Terbutaline Sulfate
Labeler / Manufacturer: Henry Schein, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION, SOLUTION
Routes: SUBCUTANEOUS
Marketing started: 20220112
Marketing ended: 20270301
FDA application: ANDA076887

## Active ingredients

- TERBUTALINE SULFATE: 1 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0404-9962"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0404-9962
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=9f4b177e-4d7d-4255-afeb-522c7d4594c6